This Phase II clinical trial evaluates the safety and efficacy of deciduous dental pulp stem cells (DPSCs) for repairing alveolar clefts in children with cleft lip and palate.
Read more »This randomized Phase I/II clinical trial evaluates the safety and efficacy of allogeneic dental pulp stem cells (DPSCs) for treating patients with acute ischemic stroke.
Read more »This Phase I/II clinical study evaluates the safety and therapeutic potential of dental pulp stem cells (DPSCs) for improving glucose control and pancreatic function in patients with type 2 diabetes.
Read more »This clinical trial evaluates the safety and efficacy of dental pulp stem cells (DPSCs) for improving pancreatic islet function and glycemic control in diabetic patients with significantly reduced islet function.
Read more »This Early Phase I clinical trial evaluates the safety and efficacy of dental pulp stem cells (DPSCs) for treating patients with primary mild to moderate knee osteoarthritis.
Read more »This Phase II clinical trial evaluates the safety and efficacy of human dental pulp stem cells for regenerating periodontal tissue in patients with chronic periodontitis.
Read more »This Phase I/II clinical trial evaluates the safety and efficacy of dental pulp stem cells (DPSCs) as a regenerative therapy for patients with depression.
Read more »This Phase III clinical trial evaluates the safety and efficacy of human dental pulp stem cells as a regenerative therapy for patients with Huntington's disease.
Read more »